|
SAMD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.195650E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.900000E-01 |
| Normal-vs-Stage2 |
2.343200E-01 |
| Normal-vs-Stage3 |
4.501200E-01 |
| Normal-vs-Stage4 |
4.739600E-03 |
| Stage1-vs-Stage2 |
5.367200E-01 |
| Stage1-vs-Stage3 |
8.189600E-01 |
| Stage1-vs-Stage4 |
1.275700E-02 |
| Stage2-vs-Stage3 |
4.991600E-01 |
| Stage2-vs-Stage4 |
1.191830E-01 |
| Stage3-vs-Stage4 |
1.406480E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.596180E-01 |
| Normal-vs-AfricanAmerican |
3.242000E-02 |
| Normal-vs-Asian |
2.544000E-01 |
| Caucasian-vs-AfricanAmerican |
1.975570E-01 |
| Caucasian-vs-Asian |
5.658600E-01 |
| AfricanAmerican-vs-Asian |
9.513000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.779500E-02 |
| Normal-vs-Female |
2.245200E-01 |
| Male-vs-Female |
3.304600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.266000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.208020E-01 |
| Normal-vs-Age(61-80Yrs) |
1.173980E-01 |
| Normal-vs-Age(81-100Yrs) |
9.331200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.479000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.420800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.435800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.019200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.894000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.052000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.980700E-03 |
| Normal-vs-Grade 2 |
5.131600E-01 |
| Normal-vs-Grade 3 |
2.836800E-01 |
| Normal-vs-Grade 4 |
6.431600E-04 |
| Grade 1-vs-Grade 2 |
5.762700E-03 |
| Grade 1-vs-Grade 3 |
2.299900E-02 |
| Grade 1-vs-Grade 4 |
6.028800E-01 |
| Grade 2-vs-Grade 3 |
4.838400E-01 |
| Grade 2-vs-Grade 4 |
6.777200E-04 |
| Grade 3-vs-Grade 4 |
3.036500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.872000E-01 |
| Normal-vs-ccB subtype |
7.196100E-02 |
| ccA subtype-vs-ccB subtype |
1.063560E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.425600E-01 |
| Normal-vs-N1 |
1.955520E-02 |
| N0-vs-N1 |
2.959700E-02 |
|
|
